论文部分内容阅读
目的探讨雷贝拉唑、多潘立酮联合替普瑞酮治疗反流性食管炎的疗效。方法将74例患者分成观察组和对照组,每组37例,对照组口服雷贝拉唑和多潘立酮片,观察组加服替普瑞酮,比较两组的临床疗效和不良反应。结果观察组总有效率明显高于对照组(P<0.05),不良反应低。结论雷贝拉唑、多潘立酮联合替普瑞酮治疗反流性食管炎疗效明显,不良反应少,值得推广。
Objective To investigate the efficacy of rabeprazole and domperidone in combination with teprenone in the treatment of reflux esophagitis. Methods 74 patients were divided into observation group and control group, 37 cases in each group. The rabbits in the control group were treated with rabeprazole and domperidone tablets orally. The observation group was given service teprenone. The clinical efficacy and adverse reactions of the two groups were compared. Results The total effective rate in observation group was significantly higher than that in control group (P <0.05), and adverse reactions were low. Conclusions Rabeprazole and domperidone combined with teprenone in the treatment of reflux esophagitis have obvious curative effect and few adverse reactions and are worth popularizing.